Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
The global Alimta market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Alimta is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Alimta is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Alimta is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Alimta include Eli Lilly, Abbott Healthcare, Cadila Healthcare and Eagle Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Alimta, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Alimta, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Alimta, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Alimta sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Alimta market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Alimta sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Alimta in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Alimta manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alimta sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Alimta Product Introduction
1.2 Market by Type
1.2.1 Global Alimta Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 100mg
1.2.3 500mg
1.3 Market by Application
1.3.1 Global Alimta Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pleural Mesothelioma
1.3.3 Non-small Cell Lung Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Alimta Sales Estimates and Forecasts 2019-2030
2.2 Global Alimta Revenue by Region
2.2.1 Global Alimta Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Alimta Revenue by Region (2019-2024)
2.2.3 Global Alimta Revenue by Region (2025-2030)
2.2.4 Global Alimta Revenue Market Share by Region (2019-2030)
2.3 Global Alimta Sales Estimates and Forecasts 2019-2030
2.4 Global Alimta Sales by Region
2.4.1 Global Alimta Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Alimta Sales by Region (2019-2024)
2.4.3 Global Alimta Sales by Region (2025-2030)
2.4.4 Global Alimta Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Alimta Sales by Manufacturers
3.1.1 Global Alimta Sales by Manufacturers (2019-2024)
3.1.2 Global Alimta Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alimta in 2023
3.2 Global Alimta Revenue by Manufacturers
3.2.1 Global Alimta Revenue by Manufacturers (2019-2024)
3.2.2 Global Alimta Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Alimta Revenue in 2023
3.3 Global Key Players of Alimta, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Alimta Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Alimta, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Alimta, Product Offered and Application
3.8 Global Key Manufacturers of Alimta, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Alimta Sales by Type
4.1.1 Global Alimta Historical Sales by Type (2019-2024)
4.1.2 Global Alimta Forecasted Sales by Type (2025-2030)
4.1.3 Global Alimta Sales Market Share by Type (2019-2030)
4.2 Global Alimta Revenue by Type
4.2.1 Global Alimta Historical Revenue by Type (2019-2024)
4.2.2 Global Alimta Forecasted Revenue by Type (2025-2030)
4.2.3 Global Alimta Revenue Market Share by Type (2019-2030)
4.3 Global Alimta Price by Type
4.3.1 Global Alimta Price by Type (2019-2024)
4.3.2 Global Alimta Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Alimta Sales by Application
5.1.1 Global Alimta Historical Sales by Application (2019-2024)
5.1.2 Global Alimta Forecasted Sales by Application (2025-2030)
5.1.3 Global Alimta Sales Market Share by Application (2019-2030)
5.2 Global Alimta Revenue by Application
5.2.1 Global Alimta Historical Revenue by Application (2019-2024)
5.2.2 Global Alimta Forecasted Revenue by Application (2025-2030)
5.2.3 Global Alimta Revenue Market Share by Application (2019-2030)
5.3 Global Alimta Price by Application
5.3.1 Global Alimta Price by Application (2019-2024)
5.3.2 Global Alimta Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Alimta Market Size by Type
6.1.1 US & Canada Alimta Sales by Type (2019-2030)
6.1.2 US & Canada Alimta Revenue by Type (2019-2030)
6.2 US & Canada Alimta Market Size by Application
6.2.1 US & Canada Alimta Sales by Application (2019-2030)
6.2.2 US & Canada Alimta Revenue by Application (2019-2030)
6.3 US & Canada Alimta Market Size by Country
6.3.1 US & Canada Alimta Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Alimta Sales by Country (2019-2030)
6.3.3 US & Canada Alimta Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Alimta Market Size by Type
7.1.1 Europe Alimta Sales by Type (2019-2030)
7.1.2 Europe Alimta Revenue by Type (2019-2030)
7.2 Europe Alimta Market Size by Application
7.2.1 Europe Alimta Sales by Application (2019-2030)
7.2.2 Europe Alimta Revenue by Application (2019-2030)
7.3 Europe Alimta Market Size by Country
7.3.1 Europe Alimta Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Alimta Sales by Country (2019-2030)
7.3.3 Europe Alimta Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Alimta Market Size
8.1.1 China Alimta Sales (2019-2030)
8.1.2 China Alimta Revenue (2019-2030)
8.2 China Alimta Market Size by Application
8.2.1 China Alimta Sales by Application (2019-2030)
8.2.2 China Alimta Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Alimta Market Size by Type
9.1.1 Asia Alimta Sales by Type (2019-2030)
9.1.2 Asia Alimta Revenue by Type (2019-2030)
9.2 Asia Alimta Market Size by Application
9.2.1 Asia Alimta Sales by Application (2019-2030)
9.2.2 Asia Alimta Revenue by Application (2019-2030)
9.3 Asia Alimta Sales by Region
9.3.1 Asia Alimta Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Alimta Revenue by Region (2019-2030)
9.3.3 Asia Alimta Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Alimta Market Size by Type
10.1.1 Middle East, Africa and Latin America Alimta Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Alimta Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Alimta Market Size by Application
10.2.1 Middle East, Africa and Latin America Alimta Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Alimta Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Alimta Sales by Country
10.3.1 Middle East, Africa and Latin America Alimta Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Alimta Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Alimta Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Alimta Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Eli Lilly Alimta Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Information
11.2.2 Abbott Healthcare Overview
11.2.3 Abbott Healthcare Alimta Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Abbott Healthcare Alimta Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Healthcare Recent Developments
11.3 Cadila Healthcare
11.3.1 Cadila Healthcare Company Information
11.3.2 Cadila Healthcare Overview
11.3.3 Cadila Healthcare Alimta Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Cadila Healthcare Alimta Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cadila Healthcare Recent Developments
11.4 Eagle Pharmaceuticals
11.4.1 Eagle Pharmaceuticals Company Information
11.4.2 Eagle Pharmaceuticals Overview
11.4.3 Eagle Pharmaceuticals Alimta Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Eagle Pharmaceuticals Alimta Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eagle Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Alimta Industry Chain Analysis
12.2 Alimta Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Alimta Production Mode & Process
12.4 Alimta Sales and Marketing
12.4.1 Alimta Sales Channels
12.4.2 Alimta Distributors
12.5 Alimta Customers
13 Market Dynamics
13.1 Alimta Industry Trends
13.2 Alimta Market Drivers
13.3 Alimta Market Challenges
13.4 Alimta Market Restraints
14 Key Findings in The Global Alimta Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-04
Pages: 74
USD 2900.00
(Single User License)
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 69
USD 2900.00
(Single User License)
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 85
USD 3950.00
(Single User License)
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 71
USD 4250.00
(Single User License)
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 97
USD 2900.00
(Single User License)
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 122
USD 3950.00
(Single User License)
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-04
Pages: 74
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-24
Pages: 85
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 69
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 85
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 71
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 97
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 122
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research